MedTrace Logo

Depression Treatment and Screening in Ovarian Cancer Patients

NCT00515372 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 409

Last updated 2026-03-09

No results posted yet for this study

Summary

The goal of this behavioral research study is to find a quick and effective way to identify depression in patients with ovarian, peritoneal, or fallopian tube cancer. Another goal of this study is to compare an intervention program with "enhanced" standard care to see which may be more effective in improving quality of life for these patients.

Conditions

Interventions

OTHER

Telephone Counseling

Weekly phone calls lasting about 30 minutes.

OTHER

Usual Care

Lists of professional resources and referral recommendations will be provided.

Sponsors & Collaborators

  • Lance Armstrong Foundation

    collaborator OTHER

  • National Cancer Institute (NCI)

    collaborator NIH

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Eileen H. Shinn, PhD · M.D. Anderson Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-12-20
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00515372 on ClinicalTrials.gov